115.87
BATS BZX Real-Time Price
As of 2:24pm ET
 -0.14 / -0.12%
Today’s Change
81.61
Today|||52-Week Range
132.13
+0.13%
Year-to-Date
LLY Regular Dividend: LLY began trading ex-dividend on 05/16/19. A $0.645 dividend will be paid to shareholders of record as of 05/17/19.
Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio
9:51am / Zacks.comZAK - Paid Partner Content
Hunting Hill Global Capital, LLC Buys Red Hat Inc, Celgene Corp, iShares China Large-...
May 15 / GuruFocus News - Paid Partner Content
Better Buy: Eli Lilly vs. Pfizer
May 19 / MotleyFool.comFOO - Paid Partner Content
3 Stocks With Big News Coming at ASCO 2019
May 15 / MotleyFool.com - Paid Partner Content
Lilly to Participate in UBS Global Healthcare Conference
May 16 / PR NewswirePRN - Paid Partner Content
The Zacks Analyst Blog Highlights: Alphabet, Eli Lilly, CVS, Marriott and TELUS
May 15 / Zacks.com - Paid Partner Content
Pfizer's Eczema Candidate Meets All Goals in Phase III Study
May 16 / Zacks.comZAK - Paid Partner Content
3 Top Diabetes Stocks to Watch in May
May 15 / MotleyFool.com - Paid Partner Content
Citadel Advisors LLC Buys Eli Lilly and Co, McDonald's Corp, The Walt Disney Co, Sell...
May 16 / GuruFocus NewsGURU - Paid Partner Content
Fayez Sarofim & Co Buys The Walt Disney Co, Mastercard Inc, Amazon. ...
May 14 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close116.01
Today’s open115.85
Day’s range115.00 - 116.21
Volume1,469,408
Average volume (3 months)13,282,322
Market cap$112.7B
Data as of 2:24pm ET, 05/20/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+1.41%
Earnings growth (next 5 years)+8.40%
Revenue growth (last year)+7.36%
P/E ratio44.7
Price/Sales4.87
Price/Book12.48

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+0.72+0.90%
SNYSanofi-0.37-0.88%
GSKGlaxoSmithKline-0.06-0.15%
AZNAstraZeneca-0.22-0.58%
Data as of 2:24pm ET, 05/20/2019

Financials

Next reporting dateJuly 30, 2019
EPS forecast (this quarter)$1.44
Annual revenue (last year)$24.6B
Annual profit (last year)$3.2B
Net profit margin13.16%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
David A. Ricks
Senior VP &
President-Manufacturing Operations
Myles Oneill
Corporate headquarters
Indianapolis, Indiana

Forecasts